← Leaderboards
Monika Gulia-Nuss
University Of Nevada Reno
$3,417,732
Attributed
$3,719,989
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $912.3K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,719,989 · 5
By mechanism
R01$2,013,002 · 1
R21$1,249,557 · 3
P20$457,430 · 1
Top collaborators
- Gary Blomquist2 shared
- Karen Schlauch2 shared
- Claus Tittiger2 shared
Most similar at University Of Nevada Reno
Same institution · by research overlap
- Karen Schlauch$3,628,167
- Gary Blomquist$100,753
- Claus Tittiger$100,753
Others in their field
Other Emerging Leaders on “Pathogen”
- Scott Hensley · University Of Pennsylvania$49,758,212
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$49,703,204
- Thomas Denny · Duke University$42,477,454
- Ryan Cirz · Revagenix, Inc.$40,209,479
- Sujatha Rashid · American Type Culture Collection$37,889,194
- Bala Raja · Luminostics, Inc.$28,624,460
Research focus
PathogenBlack-Legged TickBiologyInsectaMolecularLyme DiseaseVectorTicksFutureBloodAdultMessenger RnaArthropodsGenome EditingInjectionsMolecular BiologyGene ExpressionCell LineEmbryoGenesKnock-OutCrispr/Cas TechnologyCellsCulicidae
Grant awards (11)
Germline Transformation of Ticks$652,336
R01 · FY2025 · AI · contact PI
Germline Transformation of Ticks$674,386
R01 · FY2024 · AI · contact PI
Identification of stage-and tissue-specific endogenous tick promoters$237,875
R21 · FY2024 · AI · contact PI
Germline Transformation of Ticks$686,280
R01 · FY2023 · AI · contact PI
Identification of stage-and tissue-specific endogenous tick promoters$201,125
R21 · FY2023 · AI · contact PI
Cytochrome P450 G subfamily member as a putativeodor$241,111
P20 · FY2021 · GM · contact PI
Cytochrome P450 G subfamily member as a putativeodor$216,319
P20 · FY2020 · GM · contact PI
New molecular targets for pest management in the cuticle of the Lyme disease vector, Ixodes scapularis$180,442
R21 · FY2020 · AI
New molecular targets for pest management in the cuticle of the Lyme disease vector, Ixodes scapularis$222,568
R21 · FY2019 · AI
Development of transgenic protocols for the Lyme disease vector, Ixodes scapularis, for tick and tick-borne disease control$217,008
R21 · FY2019 · AI · contact PI
Development of transgenic protocols for the Lyme disease vector, Ixodes scapularis, for tick and tick-borne disease control$190,539
R21 · FY2018 · AI · contact PI